Smark Pharmaceuticals Private Limited
About Smark Pharmaceuticals Private Limited
Data last updated:
Smark Pharmaceuticals Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 27 October 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85110UP1988PTC010158. Its GSTIN is 09AAHCS1392K1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arun Kumar Sharma and Ankit Sharma.
Its last annual general meeting (AGM) was held on 05 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 296 Baba Nagarnaubasta Kanpur, Uttar Pradesh, India – 208021.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.23 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹10,786 (net margin -2.6%) and EBITDA of ₹9,998 (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
As per MCA filings, the company has satisfied charges of ₹3.2 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Smark Pharmaceuticals Private Limited's registered office is in Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address296 Baba Nagarnaubasta Kanpur, Uttar Pradesh, India – 208021
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Smark Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Smark Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Smark Pharmaceuticals Private Limited, buy the company report.
Financials of Smark Pharmaceuticals Private Limited
FY 2025 filings availableSmark Pharmaceuticals Private Limited reported revenue of ₹4.23 Lakh (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9,998 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10,786 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | -2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Smark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Smark Pharmaceuticals Private Limited
Smark Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Kumar Sharma | Director | 27 Oct 1988 | 38 Years 0 Months | Current |
| Ankit Sharma | Director | 21 Aug 2018 | 8 Years 2 Months | Current |
Peer comparison
Smark Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunchoice Pharmaceuticals Private Limited | ₹4.24 Lakh (FY 2024) | -5.0% | Moradabad, Uttar Pradesh, India | |||
| Ebullition Pharmaceuticals Private Limited | ₹4.23 Lakh (FY 2022) | -46.0% | New Delhi, Delhi, India | |||
| Smark Pharmaceuticals Private Limitedthis company | ₹4.23 Lakh (FY 2025) | -₹10,786 | -2.6% | -2.0% | Uttar Pradesh, India | |
| Rabindra Pharmaceuticals Private Limited | ₹4.22 Lakh (FY 2025) | -60.0% | Muzaffarpur, Bihar, India | |||
| Fressia Pharmaceuticals Private Limited | ₹4.17 Lakh (FY 2025) | 52.0% | Dholpur, Rajasthan, India |
To see the full peer comparison of Smark Pharmaceuticals Private Limited, buy the company report.
Auditor
Smark Pharmaceuticals Private Limited is audited by RPS & CO. CHARTERED ACCOUNTANTS for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RPS & CO. CHARTERED ACCOUNTANTS | FY 2017 | 010574C |
Shareholding
The shareholding of Smark Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Smark Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Nov 2007 | 10094340 | Bank of Baroda | ₹2 Lakh | Satisfied | |
| 13 Dec 1991 | 90278514 | State Bank of India | ₹1.2 Lakh | Satisfied |
To see the full charge records of Smark Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Smark Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Smark Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Smark Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCS1392K1ZX | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Smark Pharmaceuticals Private Limited, buy the company report.
Recent activity
Smark Pharmaceuticals Private Limited has 10 board changes on record since 1988: 2 appointments and 8 cessations. The latest: Dhawal Hajela ceased to be Additional Director on 05 Oct 2023.
6 earlier events are in the company report.
Frequently asked questions
Smark Pharmaceuticals is an active private limited company based in Uttar Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 27 October 1988 (38+ years old) and is registered under CIN U85110UP1988PTC010158.
Smark Pharmaceuticals has 2 current directors:
- Arun Kumar Sharma - Director
- Ankit Sharma - Director
The latest financial statements of Smark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 October 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Smark Pharmaceuticals is 09AAHCS1392K1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Smark Pharmaceuticals is U85110UP1988PTC010158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Smark Pharmaceuticals was incorporated on 27 October 1988, making it 38+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Smark Pharmaceuticals by revenue are Sunchoice Pharmaceuticals Private Limited, Ebullition Pharmaceuticals Private Limited, Rabindra Pharmaceuticals Private Limited, Fressia Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Dhawal Hajela ceased to be Additional Director on 05 Oct 2023. Karuna Murti ceased to be Additional Director on 06 May 2021. Ankit Sharma was appointed as Director on 21 Aug 2018. Smark Pharmaceuticals has 10 board changes on record in total.
The registered office of Smark Pharmaceuticals is at 296 Baba Nagarnaubasta Kanpur, Uttar Pradesh, India – 208021.
Smark Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
Smark Pharmaceuticals has no open charges and satisfied charges of ₹3.2 Lakh as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
